Literature DB >> 11357998

Interstitial dendritic cells of the heart harbor Trypanosoma cruzi antigens in experimentally infected dogs: importance for the pathogenesis of chagasic myocarditis.

S G Andrade1, A R Pimentel, M M de Souza, Z A Andrade.   

Abstract

Heart sections from 16 mongrel dogs, two normal controls and 14 infected with Trypanosoma cruzi, were submitted to immunohistochemical staining with either rabbit anti-cow S100 Protein monoclonal antibody or rabbit anti-T. cruzi purified specific antibody, using the peroxidase technique to investigate the participation of the interstitial dendritic cells of the heart (IDCs) in myocarditis of Chagas disease. Trypanosoma cruzi antigens were revealed as granular and dense deposits in IDC membrane in the heart of infected dogs both during acute and chronic myocarditis, but not in normal controls. Anti-S100 Protein labeled the IDCs, both in normal and infected dogs and a significant increase in the numbers of IDCs occurred in the myocardium, proportionally to the intensity of the inflammatory infiltration. These findings suggest that IDCs, probably by presenting T. cruzi antigens to immune-competent cells, play an important role in the pathogenesis of Chagas disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11357998     DOI: 10.4269/ajtmh.2000.63.64

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  9 in total

1.  Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice.

Authors:  Joshua Kotner; Rick Tarleton
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

Review 2.  Perspectives on the Trypanosoma cruzi-host cell receptor interactions.

Authors:  Fernando Villalta; Julio Scharfstein; Anthony W Ashton; Kevin M Tyler; Fangxia Guan; Shankar Mukherjee; Maria F Lima; Sandra Alvarez; Louis M Weiss; Huan Huang; Fabiana S Machado; Herbert B Tanowitz
Journal:  Parasitol Res       Date:  2009-03-13       Impact factor: 2.289

3.  Allopurinol is effective to modify the evolution of Trypanosoma cruzi infection in mice.

Authors:  Paola Gobbi; María S Lo Presti; Alicia R Fernández; Julio E Enders; Ricardo Fretes; Susana Gea; Patricia A Paglini-Oliva; Héctor W Rivarola
Journal:  Parasitol Res       Date:  2007-07-10       Impact factor: 2.289

Review 4.  Current and developing therapeutic agents in the treatment of Chagas disease.

Authors:  Werner Apt
Journal:  Drug Des Devel Ther       Date:  2010-09-24       Impact factor: 4.162

5.  Myocarditis Elicits Dendritic Cell and Monocyte Infiltration in the Heart and Self-Antigen Presentation by Conventional Type 2 Dendritic Cells.

Authors:  Katrien Van der Borght; Charlotte L Scott; Liesbet Martens; Dorine Sichien; Gert Van Isterdael; Veronika Nindl; Yvan Saeys; Louis Boon; Burkhard Ludewig; Thierry C Gillebert; Bart N Lambrecht
Journal:  Front Immunol       Date:  2018-11-21       Impact factor: 7.561

6.  Effect of treatment with cyclophosphamide in low doses upon the onset of delayed type hypersensitivity in mice chronically infected with Trypanosoma cruzi: involvement of heart interstitial dendritic cells.

Authors:  Torriceli Souza Thé; Renata Siqueira Portella; Marcos Lázaro Guerreiro; Sonia Gumes Andrade
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-09       Impact factor: 2.743

7.  Exacerbated skeletal muscle inflammation and calcification in the acute phase of infection by Mexican Trypanosoma cruzi DTUI strain.

Authors:  Andrea Vizcaíno-Castillo; Andrea Jiménez-Marín; Bertha Espinoza
Journal:  Biomed Res Int       Date:  2014-06-02       Impact factor: 3.411

8.  Immunopathological aspects of experimental Trypanosoma cruzi reinfections.

Authors:  Juliana Reis Machado; Marcos Vinícius Silva; Diego Costa Borges; Crislaine Aparecida da Silva; Luis Eduardo Ramirez; Marlene Antônia dos Reis; Lúcio Roberto Castellano; Virmondes Rodrigues; Denise Bertulucci Rocha Rodrigues
Journal:  Biomed Res Int       Date:  2014-06-24       Impact factor: 3.411

Review 9.  Revisiting the Posttherapeutic Cure Criterion in Chagas Disease: Time for New Methods, More Questions, Doubts, and Polemics or Time to Change Old Concepts?

Authors:  Marta de Lana; Olindo Assis Martins-Filho
Journal:  Biomed Res Int       Date:  2015-10-25       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.